BDBM50099784 4-{[1-(4-Carbamoyl-2-{2-[(9,10-dioxo-9,10-dihydro-phenanthrene-2-carbonyl)-amino]-acetylamino}-butyryl)-pyrrolidine-2-carbonyl]-amino}-4-(carboxymethyl-carbamoyl)-butyric acid::CHEMBL51489
SMILES NC(=O)CCC(NC(=O)CNC(=O)c1ccc-2c(c1)C(=O)C(=O)c1ccccc-21)C(=O)N1CCCC1C(=O)NC(CCC(O)=O)C(=O)NCC(O)=O
InChI Key InChIKey=GSUNVTRRYGIXEF-UHFFFAOYSA-N
Data 1 IC50
Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB
Found 1 hit for monomerid = 50099784
TargetReceptor-type tyrosine-protein phosphatase C(Homo sapiens (Human))
Astrazeneca Pharmaceuticals
Curated by ChEMBL
Astrazeneca Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 700nMAssay Description:In vitro inhibitory activity against the cytosolic portion of CD45 protein-tyrosine phosphatase using pNPP as the substrateMore data for this Ligand-Target Pair